D Ormond
Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 28 | 2025 | 1238 | 5.740 |
Why?
| | Neurosurgical Procedures | 12 | 2025 | 197 | 3.570 |
Why?
| | Glioblastoma | 14 | 2023 | 345 | 3.060 |
Why?
| | Meningeal Neoplasms | 6 | 2022 | 100 | 2.560 |
Why?
| | Meningioma | 6 | 2022 | 91 | 2.140 |
Why?
| | Pituitary Neoplasms | 4 | 2025 | 190 | 2.060 |
Why?
| | Adenoma | 4 | 2025 | 230 | 2.010 |
Why?
| | Glioma | 8 | 2024 | 395 | 1.930 |
Why?
| | Craniotomy | 4 | 2021 | 77 | 1.710 |
Why?
| | Neurosurgery | 3 | 2019 | 39 | 1.620 |
Why?
| | Neurosurgeons | 7 | 2025 | 19 | 1.550 |
Why?
| | Evidence-Based Medicine | 7 | 2025 | 740 | 1.530 |
Why?
| | Neoplasm Recurrence, Local | 6 | 2024 | 1079 | 1.120 |
Why?
| | Brain Mapping | 2 | 2021 | 503 | 1.090 |
Why?
| | Hydrocephalus | 3 | 2023 | 106 | 1.050 |
Why?
| | Radiosurgery | 3 | 2025 | 344 | 0.950 |
Why?
| | Cerebral Cortex | 2 | 2019 | 433 | 0.840 |
Why?
| | Perioperative Care | 1 | 2025 | 178 | 0.830 |
Why?
| | Meningeal Carcinomatosis | 1 | 2023 | 8 | 0.810 |
Why?
| | Postoperative Complications | 6 | 2019 | 2654 | 0.800 |
Why?
| | Pineal Gland | 1 | 2021 | 16 | 0.730 |
Why?
| | Pinealoma | 1 | 2021 | 10 | 0.730 |
Why?
| | Neuroendoscopy | 2 | 2020 | 23 | 0.700 |
Why?
| | Neuropathology | 1 | 2020 | 4 | 0.690 |
Why?
| | Telepathology | 1 | 2020 | 4 | 0.690 |
Why?
| | Anesthesia, General | 1 | 2021 | 77 | 0.690 |
Why?
| | Conscious Sedation | 1 | 2021 | 92 | 0.680 |
Why?
| | Wakefulness | 1 | 2021 | 125 | 0.680 |
Why?
| | Fluorescein | 1 | 2020 | 25 | 0.660 |
Why?
| | Stereotaxic Techniques | 1 | 2020 | 39 | 0.660 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2020 | 52 | 0.650 |
Why?
| | Colloid Cysts | 1 | 2019 | 2 | 0.640 |
Why?
| | Oxidants | 1 | 2020 | 111 | 0.640 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 60 | 0.640 |
Why?
| | Epilepsy, Temporal Lobe | 2 | 2019 | 38 | 0.630 |
Why?
| | Corpus Callosum | 1 | 2019 | 71 | 0.620 |
Why?
| | Isocitrate Dehydrogenase | 5 | 2024 | 59 | 0.610 |
Why?
| | Humans | 62 | 2025 | 137585 | 0.600 |
Why?
| | Neurologic Examination | 1 | 2019 | 110 | 0.600 |
Why?
| | International Educational Exchange | 1 | 2018 | 12 | 0.600 |
Why?
| | Neoplasm Grading | 5 | 2024 | 307 | 0.590 |
Why?
| | Brain | 3 | 2023 | 2668 | 0.550 |
Why?
| | Contraceptives, Oral, Hormonal | 1 | 2017 | 33 | 0.550 |
Why?
| | Reperfusion Injury | 1 | 2020 | 279 | 0.550 |
Why?
| | Education, Medical | 1 | 2020 | 266 | 0.520 |
Why?
| | Endoscopy | 1 | 2019 | 318 | 0.520 |
Why?
| | Breast Neoplasms | 4 | 2023 | 2253 | 0.520 |
Why?
| | Frailty | 1 | 2019 | 170 | 0.510 |
Why?
| | Retrospective Studies | 16 | 2023 | 15657 | 0.500 |
Why?
| | Ketones | 1 | 2016 | 49 | 0.500 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2016 | 33 | 0.500 |
Why?
| | Progesterone | 1 | 2017 | 254 | 0.490 |
Why?
| | Decompression, Surgical | 1 | 2016 | 106 | 0.480 |
Why?
| | Adult | 28 | 2023 | 37929 | 0.480 |
Why?
| | Demyelinating Diseases | 1 | 2016 | 85 | 0.480 |
Why?
| | Seizures | 3 | 2017 | 426 | 0.470 |
Why?
| | Astrocytoma | 1 | 2016 | 128 | 0.460 |
Why?
| | Patient Discharge | 2 | 2019 | 897 | 0.460 |
Why?
| | Orbital Diseases | 2 | 2016 | 32 | 0.460 |
Why?
| | Prostatic Neoplasms | 2 | 2020 | 1043 | 0.450 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 246 | 0.440 |
Why?
| | Antineoplastic Agents | 3 | 2021 | 2129 | 0.430 |
Why?
| | Third Ventricle | 2 | 2017 | 17 | 0.430 |
Why?
| | Curcumin | 1 | 2014 | 29 | 0.420 |
Why?
| | Mitochondria | 1 | 2020 | 948 | 0.420 |
Why?
| | Altitude | 1 | 2018 | 488 | 0.420 |
Why?
| | Spinal Fusion | 1 | 2016 | 251 | 0.410 |
Why?
| | Genomics | 1 | 2018 | 795 | 0.390 |
Why?
| | Stem Cell Transplantation | 1 | 2014 | 176 | 0.390 |
Why?
| | Clinical Competence | 1 | 2020 | 1118 | 0.380 |
Why?
| | Female | 28 | 2023 | 73304 | 0.380 |
Why?
| | Aged | 17 | 2022 | 23961 | 0.370 |
Why?
| | Curriculum | 1 | 2018 | 992 | 0.370 |
Why?
| | Middle Aged | 18 | 2021 | 33479 | 0.370 |
Why?
| | Adenocarcinoma | 1 | 2019 | 940 | 0.360 |
Why?
| | Neurons | 1 | 2020 | 1590 | 0.350 |
Why?
| | Polyethylene Glycols | 1 | 2016 | 641 | 0.350 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2828 | 0.340 |
Why?
| | Recovery of Function | 2 | 2015 | 653 | 0.340 |
Why?
| | Epidermal Cyst | 1 | 2010 | 11 | 0.330 |
Why?
| | Spinal Cord Injuries | 1 | 2014 | 212 | 0.330 |
Why?
| | Treatment Outcome | 10 | 2023 | 10811 | 0.330 |
Why?
| | Diffusion Tensor Imaging | 2 | 2021 | 79 | 0.330 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2526 | 0.320 |
Why?
| | Tanzania | 2 | 2020 | 58 | 0.320 |
Why?
| | Male | 21 | 2021 | 67762 | 0.310 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1587 | 0.300 |
Why?
| | Neoplasms, Neuroepithelial | 1 | 2008 | 16 | 0.290 |
Why?
| | Internship and Residency | 1 | 2018 | 1147 | 0.290 |
Why?
| | Evidence-Based Practice | 2 | 2020 | 229 | 0.290 |
Why?
| | History, 16th Century | 2 | 2019 | 16 | 0.270 |
Why?
| | History, 18th Century | 2 | 2019 | 19 | 0.270 |
Why?
| | History, 19th Century | 2 | 2019 | 60 | 0.270 |
Why?
| | Disease Progression | 5 | 2021 | 2757 | 0.250 |
Why?
| | History, 20th Century | 2 | 2019 | 325 | 0.240 |
Why?
| | Hyponatremia | 1 | 2025 | 42 | 0.230 |
Why?
| | Young Adult | 8 | 2021 | 13209 | 0.230 |
Why?
| | Disease Management | 3 | 2024 | 628 | 0.230 |
Why?
| | Mutation | 5 | 2024 | 3958 | 0.220 |
Why?
| | Sphenoid Bone | 2 | 2016 | 17 | 0.220 |
Why?
| | Benchmarking | 1 | 2025 | 186 | 0.210 |
Why?
| | Brain Edema | 1 | 2023 | 61 | 0.200 |
Why?
| | Neuroimaging | 1 | 2025 | 259 | 0.200 |
Why?
| | Aromatase | 1 | 2023 | 32 | 0.200 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2025 | 752 | 0.200 |
Why?
| | Bevacizumab | 2 | 2021 | 138 | 0.200 |
Why?
| | Congresses as Topic | 1 | 2024 | 233 | 0.200 |
Why?
| | Dacarbazine | 3 | 2022 | 98 | 0.200 |
Why?
| | Aged, 80 and over | 4 | 2019 | 7635 | 0.200 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2019 | 1396 | 0.200 |
Why?
| | Aquaporin 4 | 2 | 2023 | 94 | 0.200 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 6 | 0.180 |
Why?
| | Artificial Intelligence | 1 | 2025 | 279 | 0.180 |
Why?
| | Neuroblastoma | 1 | 2023 | 160 | 0.180 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2021 | 21 | 0.180 |
Why?
| | Evoked Potentials, Motor | 1 | 2021 | 46 | 0.180 |
Why?
| | Tumor Microenvironment | 2 | 2024 | 674 | 0.180 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1276 | 0.180 |
Why?
| | Antineoplastic Agents, Alkylating | 2 | 2022 | 73 | 0.170 |
Why?
| | Tumor Necrosis Factors | 1 | 2020 | 11 | 0.170 |
Why?
| | Quality of Life | 3 | 2023 | 2892 | 0.170 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2020 | 63 | 0.170 |
Why?
| | Estrogens | 1 | 2023 | 367 | 0.160 |
Why?
| | Androgen Antagonists | 1 | 2020 | 82 | 0.160 |
Why?
| | Multimodal Imaging | 1 | 2020 | 113 | 0.160 |
Why?
| | History, 15th Century | 1 | 2019 | 12 | 0.160 |
Why?
| | Coculture Techniques | 1 | 2020 | 239 | 0.160 |
Why?
| | Gene Knockdown Techniques | 1 | 2020 | 327 | 0.150 |
Why?
| | Parenchymal Tissue | 1 | 2019 | 6 | 0.150 |
Why?
| | Transcriptional Regulator ERG | 1 | 2019 | 18 | 0.150 |
Why?
| | Microsurgery | 1 | 2019 | 75 | 0.150 |
Why?
| | Germany | 1 | 2019 | 121 | 0.150 |
Why?
| | Receptor, trkB | 1 | 2019 | 33 | 0.150 |
Why?
| | Risk Assessment | 2 | 2019 | 3457 | 0.150 |
Why?
| | Prognosis | 4 | 2021 | 4030 | 0.150 |
Why?
| | Neurofibromin 2 | 1 | 2018 | 3 | 0.150 |
Why?
| | Smoothened Receptor | 1 | 2018 | 6 | 0.150 |
Why?
| | Hydrogen Peroxide | 1 | 2020 | 328 | 0.150 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2019 | 73 | 0.150 |
Why?
| | Serine Endopeptidases | 1 | 2019 | 123 | 0.140 |
Why?
| | Necrosis | 1 | 2019 | 246 | 0.140 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2019 | 131 | 0.140 |
Why?
| | Capacity Building | 1 | 2018 | 63 | 0.140 |
Why?
| | Colorado | 2 | 2018 | 4565 | 0.140 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 383 | 0.140 |
Why?
| | White Matter | 1 | 2019 | 145 | 0.140 |
Why?
| | Algorithms | 1 | 2025 | 1704 | 0.140 |
Why?
| | PTEN Phosphohydrolase | 1 | 2019 | 167 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 5 | 2025 | 3566 | 0.140 |
Why?
| | Thalamic Diseases | 1 | 2017 | 3 | 0.140 |
Why?
| | Multiple Sclerosis | 1 | 2023 | 455 | 0.140 |
Why?
| | DNA Helicases | 1 | 2019 | 145 | 0.140 |
Why?
| | Postoperative Hemorrhage | 1 | 2018 | 86 | 0.130 |
Why?
| | Premenopause | 1 | 2017 | 131 | 0.130 |
Why?
| | Cell Survival | 1 | 2020 | 1120 | 0.130 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2019 | 190 | 0.130 |
Why?
| | Immunotherapy | 1 | 2021 | 641 | 0.130 |
Why?
| | Benzophenones | 1 | 2016 | 16 | 0.130 |
Why?
| | Developing Countries | 1 | 2018 | 307 | 0.130 |
Why?
| | Intraoperative Complications | 1 | 2017 | 138 | 0.130 |
Why?
| | Cysts | 1 | 2017 | 113 | 0.120 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2016 | 220 | 0.120 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2019 | 202 | 0.120 |
Why?
| | Child | 6 | 2022 | 21935 | 0.120 |
Why?
| | Radiotherapy, Intensity-Modulated | 1 | 2016 | 142 | 0.120 |
Why?
| | Radiotherapy | 1 | 2016 | 201 | 0.120 |
Why?
| | Faculty, Medical | 1 | 2018 | 283 | 0.120 |
Why?
| | Estradiol | 1 | 2019 | 521 | 0.120 |
Why?
| | Frontal Bone | 1 | 2015 | 21 | 0.120 |
Why?
| | Anticonvulsants | 1 | 2017 | 217 | 0.120 |
Why?
| | Olfactory Pathways | 1 | 2015 | 36 | 0.120 |
Why?
| | Adamantinoma | 1 | 2015 | 4 | 0.120 |
Why?
| | Exophthalmos | 2 | 2016 | 18 | 0.120 |
Why?
| | Encephalocele | 1 | 2014 | 10 | 0.120 |
Why?
| | Epilepsy, Rolandic | 1 | 2014 | 1 | 0.110 |
Why?
| | Electrodes, Implanted | 1 | 2015 | 109 | 0.110 |
Why?
| | Sensorimotor Cortex | 1 | 2014 | 5 | 0.110 |
Why?
| | Temporal Bone | 1 | 2014 | 45 | 0.110 |
Why?
| | Orbit | 1 | 2015 | 70 | 0.110 |
Why?
| | Risk Factors | 2 | 2019 | 10388 | 0.110 |
Why?
| | History, 17th Century | 1 | 2014 | 16 | 0.110 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2014 | 62 | 0.110 |
Why?
| | Adolescent | 6 | 2021 | 21513 | 0.110 |
Why?
| | Biopsy | 1 | 2017 | 1129 | 0.100 |
Why?
| | Oxidative Stress | 1 | 2020 | 1317 | 0.100 |
Why?
| | Drug Resistant Epilepsy | 1 | 2015 | 102 | 0.100 |
Why?
| | Tibia | 1 | 2015 | 178 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2691 | 0.100 |
Why?
| | Organ Size | 1 | 2014 | 477 | 0.100 |
Why?
| | Reoperation | 1 | 2015 | 573 | 0.100 |
Why?
| | Polymers | 1 | 2016 | 490 | 0.100 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5757 | 0.100 |
Why?
| | Neural Stem Cells | 1 | 2014 | 156 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3284 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 528 | 0.090 |
Why?
| | Cell Proliferation | 2 | 2021 | 2475 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1502 | 0.090 |
Why?
| | Epilepsy | 1 | 2015 | 333 | 0.090 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 411 | 0.090 |
Why?
| | Eye Pain | 1 | 2010 | 7 | 0.080 |
Why?
| | Child, Preschool | 4 | 2019 | 11074 | 0.080 |
Why?
| | Combined Modality Therapy | 3 | 2019 | 1236 | 0.080 |
Why?
| | Follow-Up Studies | 2 | 2016 | 5131 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2017 | 3556 | 0.080 |
Why?
| | Body Weight | 1 | 2014 | 985 | 0.080 |
Why?
| | Headache | 1 | 2010 | 147 | 0.080 |
Why?
| | Animals | 4 | 2023 | 36940 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2837 | 0.080 |
Why?
| | Mice | 3 | 2023 | 17787 | 0.080 |
Why?
| | Cerebral Ventriculography | 1 | 2008 | 3 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 2486 | 0.070 |
Why?
| | Magnetic Resonance Angiography | 1 | 2010 | 240 | 0.070 |
Why?
| | Infant | 2 | 2019 | 9465 | 0.070 |
Why?
| | Prospective Studies | 1 | 2019 | 7604 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2010 | 1483 | 0.060 |
Why?
| | Hemorrhage | 1 | 2010 | 722 | 0.060 |
Why?
| | Rats | 1 | 2014 | 5647 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1692 | 0.060 |
Why?
| | Caregivers | 2 | 2023 | 877 | 0.060 |
Why?
| | Recurrence | 2 | 2019 | 1060 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 1724 | 0.050 |
Why?
| | Epigenomics | 1 | 2024 | 115 | 0.050 |
Why?
| | Edema | 1 | 2023 | 130 | 0.050 |
Why?
| | Genes, p16 | 1 | 2022 | 20 | 0.050 |
Why?
| | Platinum Compounds | 1 | 2022 | 10 | 0.050 |
Why?
| | Transferases | 1 | 2022 | 33 | 0.050 |
Why?
| | Rare Diseases | 1 | 2022 | 104 | 0.050 |
Why?
| | Astrocytes | 1 | 2023 | 210 | 0.050 |
Why?
| | Information Dissemination | 1 | 2022 | 218 | 0.040 |
Why?
| | Chromosomes, Human, Pair 19 | 1 | 2019 | 25 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2023 | 327 | 0.040 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2019 | 71 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 5778 | 0.040 |
Why?
| | Cost of Illness | 1 | 2021 | 308 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 660 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2023 | 893 | 0.040 |
Why?
| | Central Nervous System | 1 | 2020 | 258 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2022 | 493 | 0.040 |
Why?
| | Diagnostic Imaging | 1 | 2020 | 332 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2020 | 658 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1710 | 0.030 |
Why?
| | Machine Learning | 1 | 2022 | 493 | 0.030 |
Why?
| | Ventriculostomy | 1 | 2017 | 21 | 0.030 |
Why?
| | DNA Methylation | 1 | 2022 | 643 | 0.030 |
Why?
| | Cerebrospinal Fluid | 1 | 2017 | 92 | 0.030 |
Why?
| | Receptor, ErbB-2 | 1 | 2019 | 341 | 0.030 |
Why?
| | Drainage | 1 | 2017 | 173 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1272 | 0.030 |
Why?
| | Subdural Space | 1 | 2015 | 8 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 580 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1389 | 0.030 |
Why?
| | Olfactory Nerve | 1 | 2015 | 3 | 0.030 |
Why?
| | Cohort Studies | 2 | 2016 | 5742 | 0.030 |
Why?
| | Mastoid | 1 | 2014 | 13 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1459 | 0.030 |
Why?
| | Nasal Cavity | 1 | 2015 | 52 | 0.030 |
Why?
| | Cerebral Arteries | 1 | 2015 | 59 | 0.030 |
Why?
| | Gait Disorders, Neurologic | 1 | 2015 | 46 | 0.030 |
Why?
| | Video Recording | 1 | 2015 | 180 | 0.030 |
Why?
| | Personality Disorders | 1 | 2015 | 75 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 967 | 0.030 |
Why?
| | Keratins | 1 | 2015 | 173 | 0.030 |
Why?
| | Carmustine | 1 | 2014 | 50 | 0.030 |
Why?
| | Absorbable Implants | 1 | 2014 | 35 | 0.030 |
Why?
| | Treatment Failure | 1 | 2015 | 356 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2553 | 0.030 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2015 | 179 | 0.030 |
Why?
| | Vision Disorders | 1 | 2015 | 142 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2014 | 389 | 0.020 |
Why?
| | Electroencephalography | 1 | 2015 | 423 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2014 | 686 | 0.020 |
Why?
| | Otitis Media | 1 | 2014 | 165 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 500 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2189 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2023 | 6079 | 0.020 |
Why?
| | Hearing Loss | 1 | 2014 | 221 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4193 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2015 | 496 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3412 | 0.020 |
Why?
| | Drug Delivery Systems | 1 | 2014 | 365 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1357 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2015 | 1023 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2031 | 0.020 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2014 | 804 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2015 | 1164 | 0.020 |
Why?
| | Cognition | 1 | 2015 | 1153 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 5079 | 0.010 |
Why?
|
|
Ormond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|